Furthermore, dosage-dependent antisense oligonucleotide knock-down of dync1h1 revealed outer segment abnormalities in the ...
Preincubation of CF-T43 cells with CFTR anti-sense oligonucleotides prevented an increase in 36Cl- efflux in response to beta- ...
We developed antisense oligonucleotides that suppressed AR gene expression in the periphery but not the CNS after subcutaneous ...
Oligonucleotides, Antisense / administration & dosage * Organometallic Compounds / administration & dosage * Organometallic ...
Oligonucleotides, Antisense Grants and funding * AI-20001/AI/NIAID NIH HHS/United States ...
Oligonucleotides, Antisense Grants and funding * R01 AA011576/AA/NIAAA NIH HHS/United States ...
Antisense oligonucleotide therapy for KCNT1 encephalopathy. Burbano LE, Li M, Jancovski N, Jafar-Nejad P, Richards K, Sedo A, ...
Oligonucleotides, Antisense / metabolism * Reactive Oxygen Species / metabolism* * Regeneration* / drug effects * Tail / drug ...
Antisense oligonucleotides for therapeutic intervention. Eck SL, Nabel GJ. Eck SL, et al. Curr Opin Biotechnol. 1991 Dec;2(6): ...
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, Chiò ...
... ... Antisense mixed-backbone oligonucleotides (MBO) specifically inhibit MDM2 expression in a dose- and time-dependent manner, ... These results provide a basis for clinical evaluation of antisense anti-MDM2 oligonucleotides as chemosensitizers and ... we have chosen to use gene silencing technologies including antisense oligonucleotides and RNA interference. In this article, ...
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, Chiò ... Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. Miller T, Cudkowicz M, Shaw PJ, Andersen PM, Atassi N, ...
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, Chiò ...
Embryonic Stem Cells_control_antisense_oligonucleotide. Organism. Mus musculus. Characteristics. cell type: ES cells. cell line ...
... at an early stage of the endocytotic pathway which leads to a marked increase in antisense activity and oligonucleotide nuclear ... Oligonucleotides are delivered by cationic lipids into the cytoplasm ... Conclusions: Oligonucleotides are delivered by cationic lipids into the cytoplasm at an early stage of the endocytotic pathway ... Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids Pharm Res. 1996 Sep;13(9): ...
Identifying Antisense Oligonucleotides to Disrupt Small RNA Regulated Antibiotic Resistance via a Cell-Free Transcription- ...
Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman syndrome mouse model. ...
... antisense oligonucleotides or small interfering ribonucleic acids suppress hepatic angiotensinogen for weeks to months after 1 ...
... end elements involved in mRNA processing using antisense oligonucleotide drugs can be used as a strategy for gene silencing ... Antisense targeting of 3 end elements involved in DUX4 mRNA processing is an efficient therapeutic strategy for ... We conclude that targeting key functional 3 end elements involved in pre-mRNA to mRNA maturation with antisense drugs can lead ... and thus all mRNAs are virtually eligible for this antisense-mediated knockdown strategy. ...
ODN with a homology of 45 nucleotides showed the highest frequency and ODN with antisense orientation showed a 1000-fold higher ... Targeted gene correction by small single-stranded oligonucleotides in mammalian cells Gene Ther. 2001 Mar;8(5):391-9. doi: ... Surprisingly, these short single-stranded oligonucleotides (ODN) showed a similar gene correction frequency to chimeric RNA-DNA ... Deoxyoligonucleotides showed a higher frequency of gene correction than ribo-oligonucleotides of the identical sequence. These ...
Designing Effective Antisense Oligonucleotides for Exon Skipping.. Shimo T, Maruyama R, Yokota T. Methods Mol Biol 2018;1687: ... Tips to Design Effective Splice-Switching Antisense Oligonucleotides for Exon Skipping and Exon Inclusion. ...
Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation ...
XIAP antisense is now in clinical development in oncology.. Overall design. Human HCT116 colon cancer cell lines were ...
Fluorescent antisense cRNA was synthesized with cyanine 5-CTP (Cy5-CTP) or 3-CTP (Cy3-CTP), and T7 polymerase. The fluorescent- ... Fluorescent antisense cRNA was synthesized with cyanine 5-CTP (Cy5-CTP) or 3-CTP (Cy3-CTP), and T7 polymerase. The fluorescent- ... labeled antisense cRNA was purified with miRNeasy columns (Qiagen) according to manufacturers protocols and resuspended in ... labeled antisense cRNA was purified with miRNeasy columns (Qiagen) according to manufacturers protocols and resuspended in ...
... which may be useful near promoters where sufficient sense/anti-sense transcript mapping information is lacking. PIP-seq ...
Besides, sense to antisense reads ratio was calculated to indicate strand specificity. Hierarchical clustering and heatmap ...
Besides, sense to antisense reads ratio was calculated to indicate strand specificity. Hierarchical clustering and heatmap ...
A complex allele with an insertion of 2667 nucleotides of processed cDNA in antisense orientation of NUS1 at 6q22.31 (reference ... Utility of oligonucleotide array-based comparative genomic hybridization for detection of target gene deletions. Clin Chem. ...